GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuVasive Inc (NAS:NUVA) » Definitions » Cyclically Adjusted Price-to-FCF

NuVasive (NuVasive) Cyclically Adjusted Price-to-FCF : (As of May. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is NuVasive Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


NuVasive Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for NuVasive's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuVasive Cyclically Adjusted Price-to-FCF Chart

NuVasive Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 46.77 50.56 42.97

NuVasive Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.71 42.06 42.97 45.26 44.20

Competitive Comparison of NuVasive's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, NuVasive's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuVasive's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NuVasive's Cyclically Adjusted Price-to-FCF falls into.



NuVasive Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

NuVasive's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, NuVasive's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.009/128.7287*128.7287
=-0.009

Current CPI (Jun. 2023) = 128.7287.

NuVasive Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.549 98.790 0.715
201312 0.123 98.326 0.161
201403 0.216 99.695 0.279
201406 0.125 100.560 0.160
201409 0.746 100.428 0.956
201412 0.134 99.070 0.174
201503 -0.620 99.621 -0.801
201506 -0.180 100.684 -0.230
201509 0.017 100.392 0.022
201512 0.403 99.792 0.520
201603 0.768 100.470 0.984
201606 0.069 101.688 0.087
201609 -0.457 101.861 -0.578
201612 0.851 101.863 1.075
201703 -0.132 102.862 -0.165
201706 0.074 103.349 0.092
201709 0.433 104.136 0.535
201712 0.867 104.011 1.073
201803 0.090 105.290 0.110
201806 0.222 106.317 0.269
201809 0.907 106.507 1.096
201812 0.860 105.998 1.044
201903 -0.310 107.251 -0.372
201906 0.715 108.070 0.852
201909 0.706 108.329 0.839
201912 0.847 108.420 1.006
202003 -0.472 108.902 -0.558
202006 0.077 108.767 0.091
202009 1.023 109.815 1.199
202012 0.872 109.897 1.021
202103 0.104 111.754 0.120
202106 0.370 114.631 0.416
202109 0.643 115.734 0.715
202112 0.228 117.630 0.250
202203 -0.426 121.301 -0.452
202206 0.500 125.017 0.515
202209 0.305 125.227 0.314
202212 0.201 125.222 0.207
202303 -0.635 127.348 -0.642
202306 -0.009 128.729 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NuVasive  (NAS:NUVA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


NuVasive Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of NuVasive's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NuVasive (NuVasive) Business Description

Traded in Other Exchanges
N/A
Address
12101 Airport Way, Broomfield, CO, USA, 92121
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Executives
Michael Farrington officer: SVP, People and Culture 7475 LUSK BLVD., SAN DIEGO CA 92121
Marc W. Rosenbaum officer: Chief Accounting Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
James Christopher Barry director, officer: Chief Executive Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Andrew C. Morton officer: SVP, CHRO 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Amy Belt Raimundo director ONE KAISER PLAZA, 22ND FLOOR, OAKLAND CA 94612
Lucas Vitale officer: Chief Human Resources Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Massimo Calafiore officer: EVP, Global Business Units 7475 LUSK BLVD., SAN DIEGO CA 92121
Siddhartha Kadia director 7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Brent J. Boucher officer: EVP, Global Commercial 14 PLAZA DRIVE, LATHAM NY 12110
Matthew Link officer: Exec. VP U.S. Sales 7475 LUSK BLVD, SAN DIEGO CA 92121
Matthew K Harbaugh officer: EVP and CFO 675 MCDONNELL BLVD., HAZELWOOD MO 63042
Dale A. Wolf officer: SVP, Global Operations 7475 LUSK BLVD., SAN DIEGO CA 92121
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Paul Mcclintock officer: President, U.S. Commercial 7475 LUSK BLVD, SAN DIEGO CA 92121

NuVasive (NuVasive) Headlines